Soft regulations in pharmaceutical policy making Björn WettermarkBrian GodmanFlora M. Haaijer-Ruskamp Current Opinion 06 August 2012 Pages: 137 - 147
Value-based insurance design in medicare William E. Encinosa Current Opinion 06 August 2012 Pages: 149 - 154
Financial risk of the Biotech Industry versus the Pharmaceutical Industry Joseph GolecJohn A. Vernon Leading Article 06 August 2012 Pages: 155 - 165
Short-term cost and health consequences of duodenal levodopa infusion in advanced Parkinson’s disease in Sweden Ivar Sønbø KristiansenKerstin BingeforsDag Isacson Original Research Article 06 August 2012 Pages: 167 - 180
Economic evaluation of Sinfrontal®in the treatment of acute maxillary sinusitis in adults Kyra C. KneisAfschin Gandjour Original Research Article 06 August 2012 Pages: 181 - 191
The economic value of primary prophylaxis using pegfilgrastim compared with filgrastim in patients with breast cancer in the UK Zhimei LiuQuan V. DoanRobert Leonar Original Research Article 06 August 2012 Pages: 193 - 205